EDESA BIOTECH, INC. Payments to Acquire Investments
EDESA BIOTECH, INC. (EDSA) reported Payments to Acquire Investments of $68.90 million for the 6-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2023-05-11
- EDESA BIOTECH, INC. payments to acquire investments for the quarter ending 2019-03-31 was $933.00, a 99.81% decline year-over-year.
- EDESA BIOTECH, INC. payments to acquire investments for the quarter ending 2018-12-31 was $21.04K, a 403.98% increase year-over-year.
- EDESA BIOTECH, INC. payments to acquire investments for the quarter ending 2018-09-30 was $3.11M, a 55.98% increase year-over-year.
- EDESA BIOTECH, INC. payments to acquire investments for the quarter ending 2018-06-30 was $5.46M, a 444.61% increase year-over-year.
- EDESA BIOTECH, INC. payments to acquire investments for fiscal 2018 was $9.08M, a 81.47% increase from fiscal 2017.
- EDESA BIOTECH, INC. payments to acquire investments for fiscal 2017 was $5.01M, a 58.27% decline from fiscal 2016.
- EDESA BIOTECH, INC. payments to acquire investments for fiscal 2016 was $12.00M, a 87605.27% increase from fiscal 2015.
- EDESA BIOTECH, INC. payments to acquire investments for fiscal 2015 was $13.68K, a 99.75% decline from fiscal 2014.
| Period end | Payments to Acquire Investments 1 month | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month | Payments to Acquire Investments 12 month as first filed |
|---|---|---|---|---|---|---|
| 2023-03-31 | $68.90M 10-Q · filed 2023-05-11 | |||||
| 2019-03-31 | $933.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-08 | $21.97K 10-Q · filed 2019-05-08 | $3.14M derived: sum of 3 quarters · filed 2019-05-08 | $8.60M derived: sum of 4 quarters · filed 2019-05-08 | ||
| 2018-12-31 | $21.04K 10-Q · filed 2019-02-05 | $3.14M derived: sum of 2 quarters · filed 2019-02-05 | $8.60M derived: sum of 3 quarters · filed 2019-02-05 | $9.10M derived: sum of 4 quarters · filed 2019-05-08 | ||
| 2018-09-30 | $3.11M derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30 | $8.58M derived: sum of 2 quarters · filed 2018-11-30 | $9.08M derived: sum of 3 quarters · filed 2019-05-08 | $9.08M 10-K · filed 2018-11-30 | ||
| 2018-06-30 | $5.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-08 | $5.96M derived: sum of 2 quarters · filed 2019-05-08 | $5.97M 10-Q · filed 2018-08-08 | $7.97M derived: sum of 4 quarters · filed 2019-05-08 | ||
| 2018-03-31 | $501.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-08 | $505.22K 10-Q · filed 2019-05-08 | $2.50M derived: sum of 3 quarters · filed 2019-05-08 | $3.51M derived: sum of 4 quarters · filed 2019-05-08 | ||
| 2017-12-31 | $4.17K 10-Q · filed 2019-02-05 | $2.00M derived: sum of 2 quarters · filed 2019-02-05 | $3.00M derived: sum of 3 quarters · filed 2019-02-05 | $5.00M derived: sum of 4 quarters · filed 2019-02-05 | ||
| 2017-09-30 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30 | $3.00M derived: sum of 2 quarters · filed 2018-11-30 | $5.00M derived: sum of 3 quarters · filed 2018-11-30 | $5.01M 10-K · filed 2018-11-30 | ||
| 2017-06-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-08 | $3.00M derived: sum of 2 quarters · filed 2018-08-08 | $3.01M 10-Q · filed 2018-08-08 | $9.00M derived: sum of 4 quarters · filed 2018-08-08 | ||
| 2017-03-31 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-07 | $2.01M 10-Q · filed 2018-05-07 | $8.00M derived: sum of 3 quarters · filed 2018-05-07 | $12.00M derived: sum of 4 quarters · filed 2018-05-07 | ||
| 2016-12-31 | $4.80K 10-Q · filed 2018-02-07 | $5.99M derived: sum of 2 quarters · filed 2018-02-07 | $9.99M derived: sum of 3 quarters · filed 2018-02-07 | $12.00M derived: sum of 4 quarters · filed 2018-02-07 | ||
| 2016-09-30 | $5.99M derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01 | $9.99M derived: sum of 2 quarters · filed 2017-12-01 | $11.99M derived: sum of 3 quarters · filed 2017-12-01 | $12.00M 10-K · filed 2017-12-01 | ||
| 2016-06-30 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09 | $6.00M derived: sum of 2 quarters · filed 2017-08-09 | $6.01M 10-Q · filed 2017-08-09 | $6.01M derived: sum of 4 quarters · filed 2017-12-01 | ||
| 2016-03-31 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-09 | $2.01M 10-Q · filed 2017-05-09 | $2.01M derived: sum of 3 quarters · filed 2017-12-01 | $2.01M derived: sum of 4 quarters · filed 2017-12-01 | ||
| 2015-12-31 | $1.63K 10-Q · filed 2017-02-06 | $2.60K derived: sum of 2 quarters · filed 2017-12-01 | $8.27K derived: sum of 3 quarters · filed 2017-12-01 | $14.08K derived: sum of 4 quarters · filed 2017-12-01 | ||
| 2015-09-30 | $973.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01 | $6.64K derived: sum of 2 quarters · filed 2017-12-01 | $12.46K derived: sum of 3 quarters · filed 2017-12-01 | $13.68K 10-K · filed 2017-12-01 | ||
| 2015-06-30 | $5.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | $11.48K derived: sum of 2 quarters · filed 2016-08-09 | $12.70K 10-Q · filed 2016-08-09 | |||
| 2015-03-31 | $5.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-09 | $7.04K 10-Q · filed 2016-05-09 | ||||
| 2014-12-31 | $1.22K 10-Q · filed 2016-02-08 | |||||
| 2014-09-30 | $2.49K 10-K · filed 2016-12-14 | |||||
| 2014-08-31 | $5.47M 10-K · filed 2016-12-14 | $464.50K 10-K · filed 2014-11-21 | ||||
| 2013-08-31 | $0.00 10-K · filed 2014-11-21 | |||||
| 2012-08-31 | $0.00 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |